Full Text

Turn on search term navigation

© 2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

While growing as a community, we realised that our membership included about 10% of young rheumatologists from outside Europe (table 1 and figure 1). [...]we felt the need to broaden our perspectives by establishing collaborations with the American College of Rheumatology Young Investigators12 and with the recently established Pan American League Against Rheumatism ‘Joven’13 and the Asia & Pacific League Against Rheumatism Young Rheumatologists Group (AYR).14 Figure 1. Furthermore, we acknowledged the importance of building bridges with paediatric rheumatologists and with associations of young colleagues of other specialities involved in the care of people with RMDs to develop joint projects aimed at pursuing a holistic approach for our patients throughout their life.15 This is exemplified among others by our partnership with the EMErging RheumatoloGists and rEsearchers group within the Paediatric Rheumatology European Society (PReS),16 which flourished at the 2019 EULAR-PReS Congress with a joint session on the management of neuropsychiatric systemic lupus erythematosus across the lifespan and the allocation of a EULAR-PReS research grant to a joint project. EMEUNET has had a longstanding collaboration with Young PARE,17 from the participation in their first meeting in 2016 to the development of joint projects, some of which have been already resulted in the development of EULAR recommendations.18–20 In addition to these EMEUNET initiated task forces, the involvement of EMEUNET members in every task force for EULAR recommendations is now well established, having been incorporated in the 2014 EULAR standard operating procedures.21 While blowing out our first 10 birthday candles,22 we kept strengthening the bond with EULAR, which lead to the recognition of EMEUNET as an essential constituent of EULAR by granting it status as an independent committee in June 2019. [...]we recently achieved a milestone in the history of EMEUNET, being recognised as a EULAR Committee(Box 1).

Details

Title
EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future
Author
Alunno, Alessia 1   VIAFID ORCID Logo  ; Rivellese, Felice 2   VIAFID ORCID Logo  ; Lauper, Kim 3   VIAFID ORCID Logo  ; Aletaha, Daniel 4   VIAFID ORCID Logo  ; Buch, Maya H 5   VIAFID ORCID Logo  ; Gossec, Laure 6   VIAFID ORCID Logo  ; Mandl, Peter 4   VIAFID ORCID Logo  ; Machado, Pedro M 7   VIAFID ORCID Logo  ; Ospelt, Caroline 8   VIAFID ORCID Logo  ; Molto, Anna 9   VIAFID ORCID Logo  ; Sofia Ramiro 10 ; Nikiphorou, Elena 11   VIAFID ORCID Logo  ; Sepriano, Alexandre 12   VIAFID ORCID Logo 

 Department of Life, Health and Environmental Sciences, Internal Medicine and Nephrology Unit, University of L'Aquila, L'Aquila, Italy 
 Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, The London School of Medicine and Dentistry, Queen Mary University of London, London, UK 
 Division of Rheumatology, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland, Geneva, Switzerland; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK 
 Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria 
 Centre for Musculoskeletal & dermatological Sciences, Faculty of Biology, medicine & health, University of Manchester UK, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester, UK 
 INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Universite, Paris, France; AP-HP, Rheumatology department, Pitié Salpêtrière hospital, Sorbonne Université, Paris, France 
 Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK; National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK 
 Department of Rheumatology, Center of Experimental Rheumatology, University Hospital of Zurich, Zurich, Switzerland 
 Department of Rheumatology, Hôpital Cochin. Assistance Publique - Hôpitaux de Paris, Paris, France; INSERM U1153 Epidémiologie Clinique et Biostatistiques, PRES Sorbonne Paris-Cité, Paris, France 
10  Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands 
11  Centre for Rheumatic Diseases, King's College London, London, UK; Rheumatology Department, King’s College Hospital, London, UK 
12  Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal 
Section
Education
Publication year
2021
Publication date
Dec 2021
Publisher
BMJ Publishing Group LTD
e-ISSN
20565933
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2614565420
Copyright
© 2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.